# Novellia to Present Latest Research on GLP-1 Therapy in Breast Cancer at the 2026 San Antonio Breast Cancer Symposium

Novellia's research on GLP-1 receptor agonists in breast cancer has been accepted as a poster presentation at the 2026 San Antonio Breast Cancer Symposium (SABCS). The symposium takes place December 8-11 in San Antonio, Texas. Novellia will share the research when the poster is presented.

GLP-1s are increasingly adopted by patients with breast cancer. Novellia's research examines how that therapy is experienced, interrupted, and sustained in real-world care.

The Record Behind the Research

Novellia's mission is to help every person reclaim ownership of their health, one medical record at a time. Novellia helps patients gather their complete health record from every system, practice, and provider they have seen over the last 12 years. For a person with breast cancer, that record brings together oncology, primary care, and every other practice involved in their care.

Research Centered on the Patient

Patients who use Novellia choose to consent to the use of their de-identified data for medical research, contributing evidence that can improve care for others. Researchers receive consented, de-identified, longitudinal records that show when a therapy begins, changes, and continues across providers and settings. That view makes it possible to study the experience of treatment as it unfolds over time.

Why SABCS Matters

SABCS is the largest breast cancer research conference in the world, drawing about 10,000 attendees from more than 100 countries. Physicians, researchers, and patient advocates gather to review the latest work in the prevention, diagnosis, and treatment of breast cancer. Presenting at SABCS gives Novellia a chance to share its belief that research centered and consented by the patient fills gaps often left behind by traditional datasets like claims or single-source EHR.

Frequently Asked Questions

What are GLP-1 receptor agonists?

GLP-1 receptor agonists are a class of medicines that act on the glucagon-like peptide-1 pathway, which helps regulate blood sugar and appetite. They are prescribed for conditions that include type 2 diabetes and chronic weight management.

What is the San Antonio Breast Cancer Symposium?

SABCS is an annual scientific meeting on breast cancer research and care. Its program includes expert lectures, selected slide and poster presentations, forums, and case discussions.

When and where is SABCS 2026?

SABCS 2026 takes place December 8-11 at the Henry B. González Convention Center in San Antonio, Texas. Novellia's research will be presented as a poster.

‍